Fake Growth, Real Risk: The Companies Posting Big Numbers With Rotten Fundamentals

“Big numbers” are intoxicating: 60% revenue growth, record bookings, millions of active users, “adjusted EBITDA” that magically turns losses into profits. Sometimes it’s real momentum. But sometimes it’s low-quality (or manufactured) growth that looks great on a slide deck and ugly in the cash flow statement, the balance sheet, or the footnotes.

TL;DR

• “Fake growth” isn’t usually about one bad quarter—it’s a pattern: headline metrics up, cash and unit economics not keeping up.
• Start with cash: if you find that a company’s operating cash flow has been persistently lagging behind net income (or revenue), treat the story with skepticism until you understand why.
• Watch the balance sheet: receivables and inventory turnover and other lines like capitalized costs and “other assets” can give away where the company is pulling earnings forward.
• Be tough on non-GAAP: if a company has recurring add-backs for stock-based compensation or “one-time” charges that happen every year or aggressive revenue metrics, it’s evidence of rot beneath the surface.
• Use filings, not marketing: SEC EDGAR + 10-K/10-Q footnotes + the non-GAAP reconciliation is where the real story lives.

What “Fake Growth” usually looks like in practice

In most real-world blowups, the early warning sign isn’t a scandal breaking. It’s a divergence between the numbers that are easy to hype (revenue grow! users grow! adjusted profits grow! backlog grow!) and the numbers that are hard to fake for long (generating cash, margins that don’t waver, repeat purchases, healthy balance sheets).

• Income statement looks solid, but cash flow statement looks weak (or just keeps getting weaker as “growth” speeds up).
• Sales are up, but accounts receivable are up even more (cash collections don’t keep up).
• Margins are “temporarily pressured,” but the business is spending even more in an attempt to fake demand.
• Non-GAAP earnings look great because the same “one-time” adjustments “one-time” repeat quarter after quarter.
• KPIs look like they are growing, only the definition for what constitutes an “active user” or “booking” or “customer” keeps changing over time.

Rotten Fundamentals: The 4 Buckets That Matter

When investors say “the fundamentals are rotten,” what they typically mean is that one (or more) of these are true. The headline number may still be getting bigger, but the engine is falling apart.

Red Flags That Big Numbers Are Hiding Weakness

• Operating cash flow trails net income and maybe flips negative at some point even as profits improve.
• Accounts receivable growing faster than revenue, DSO past trend moving up.
• Inventory growing faster than revenue, inventory turnover slowing, suggesting demand for the product may be much weaker than what has been inferred from sales.
• The revenue “growth story” breaks and low-ball pricing/reduced recognition of costs becomes visible as gross margin declines but “record revenue” continues to get reported.
• Improving “Adjusted EBITDA,” but GAAP operating loss or GAAP net loss remains stubbornly large.
• Company routinely adds back stock-based compensation, restructuring, litigation/acquisition-related costs as if they’re non-recurring (even when they recur).
• Have large “capitalized” costs that grow quickly (software development, contract acquisition costs, content/library costs, etc.), which boosts current earnings at the expense of future amortization of those costs.
• Getting a spike in shipments/sales at quarter end, unusually large distributor purchases, or heavy incentives that pull demand forward (classic channel stuffing dynamics).
• Big growth in “billings,” “bookings,” or “GMV” that doesn’t bridge clearly to recognized revenue/cash receipts.
• Frequent changes to KPI definitions, cohorts, or reporting periods that make trends hard to compare.
• Rising leverage or issuing new equity repeatedly to fund operations (not just strategic investment).
• An increasing “other current assets” / “other long-term assets” line that grabs your eye but does not cleanly explain itself in footnotes.

A Practical 30-Minute “Quality of Growth” Check (Using Public Filings)

You don’t need a forensic accounting team to do a first-pass screen. You need the last a few 10-Qs, the most recent 10-K, and discipline about where to look first. If you can’t explain the movements in cash flow and the balance sheet, you don’t understand the “growth.”

1. Pull filings from SEC EDGAR (start with the most recent 10-K and the last 2–4 10-Qs).
2. Start at the statement of cash flows: compare net income to net cash provided by (used in) operating activities. Note the direction over time, not just one quarter.
3. Scan the operating cash flow reconciliation: identify the biggest drivers (receivables, inventory, payables, deferred revenue, “other assets/liabilities”). Ask: is this company generating cash – or borrowing it from their balance sheet?
4. Look at working-capital intensity: is it the case that revenue is up 30% but receivables are up 60%? Write down the explanation you expect to find in MD&A.
5. Check gross margin trend and sales efficiency: is this company presumably buying its growth with discounts and incentives that make each dollar sold less efficient? Or with rising fulfillment costs?
6. Read the non-GAAP reconciliation (usually found in the classic earnings materials and in filings, if briefly). List every adjustment that you will find over and over; these must then be thought of as “part of the structure of cost”.
7. Inspect share count and stock based compensation: “adjusted profits” can still be a heaving damn dump on the heads of minority shareholders.
8. Read the revenue recognition and significant accounting policy footnotes: especially around returns, incentives, principal v agent, contract terms.
9. Search the filing for quarter-end, incentives, returns, x-extended payment terms, right of return, bill-and-hold, material weakness. This is where the “truth” often hides.
10. Compare and contrast with the datapoint supplied by management’s narrative around their own key metrics. Is the phrasing precise? Are the definitions changing? Increasing in either number period-over-period because of demand or policy/measurement/product desires?

• Footnotes on revenue recognition: additional detail on returns, incentives, timing, and/or how to think about contract structure and the effect on revenue recognition.
• Non-GAAP reconciliation: see the company’s own “map” showing what it’s excluding.
• MD&A: management’s explanation of what really changed and why (of course, you’ll also find what they’re not emphasizing). Look to find key things packed away here.
• Risk factors: these can actually be a good place to find risks to the business—packaged in optimistic seeming but hypothetical language—look for them here even if they really are already happening. They may not “always” pop up here, but frequently do.

Non-GAAP & KPI Tricks: Not Always Glaring, But Easy To Abuse

Non-GAAP and KPI measures can genuinely be interesting and valuable for investors (especially in earlier stage or subscription businesses). With GAAP timing not perfectly matching economics, it’s interesting to see other ways to look at the business. But the “alternative” number becomes a problem when it’s the only number that’s important, and when it’s used to bury real costs.

In the U.S., SEC rules/guidance do require that non-GAAP presentations are reconciled to the most comparable GAAP measure, and that they’re presented without giving the non-GAAP more prominence than GAAP. Separately, SEC guidance for the “MD&A” section also discusses how companies should present KPIs/metrics with clear definitions, calculation methods, and reasons for period-to-period changes.

Common “big numbers” and how to pressure-test them

A Real-World Pattern: “Meeting the Number” by Pulling Demand Forward

One of the most common ways companies manufacture short-term growth is by pulling future demand into the current quarter—often through unusual incentives, extended payment terms, or distributor loading. It can create the illusion of momentum, but it frequently shows up later as weaker future sales, higher returns, or margin pressure.

Four Documented Examples (Big Numbers That Didn’t Hold Up)

The goal here isn’t to “name and shame”. It’s to show how the pattern can play out – from aggressive sales tactics to outright fabrication – and what an investor could have pressure-tested earlier using filings and basic financial statement linkage.

1) Bristol-Myers Squibb (SEC settlement over channel stuffing)

In 2004, the SEC announced an enforcement action and settlement with Bristol-Myers Squibb, describing how, for a time, the company allegedly deceived the market about meeting projections by relying heavily on channel stuffing and related accounting tactics. The takeaway for investors: if a company appears to be “consistently meeting expectations”, look for evidence of demand being pulled forward – often visible in channel inventory build, receivables movement, and language about incentives.

2) Elanco Animal Health (SEC action over undisclosed incentivized sales practices)

In November 2024, the SEC announced settled antifraud charges against Elanco Animal Health related to statements about revenue growth and end-user demand, where the SEC described the company’s reliance on quarter-end sales incentives that led distributors to purchase more than end-user demand would suggest. The investor lesson: sales can be “real” in the accounting sense but still fragile economically if they’re being driven by incentives that have hangover future quarters.

3) Luckin Coffee (SEC settlement over fabricated sales transactions)

Some readers may remember the Luckin Coffee story, which is a tale of learning from “growth” disguised as financial mismanagement. In December 2020, the SEC announced that Luckin Coffee had agreed to pay a civil penalty to settle accounting fraud charges, with the SEC saying that the company fabricated retail sales transactions (along with other misstatements) to appear to achieve rapid growth.
The lesson here? “Growth” without strong internal controls and transparent disclosure isn’t just a valuation risk—it becomes an existential risk.

4) Wirecard (missing cash and reported accounting problems leading to collapse)

Wirecard shocked in June 2020 when it disclosed that auditors were unable to account for €1.9 billion of cash that was reported on its balance sheet and subsequently filed for insolvency. To be clear, the lesson here isn’t “never trust reported cash.” It’s when a company’s business model is heavily dependent on opaque third parties or complex structures, the burden of proof should rise, and investors should be extra strict about disclosure quality and consistency.

If You Want One Screening Tool: Use It, but Don’t Worship It

Quant screens can help you prioritize what to read. One popular example in the community is the Beneish M-Score framework (which originally was created to help detect the probability of earnings manipulation using accounting variables). It’s not proof of fraud and can create false positives—especially if applied to fast-changing businesses. But it can be useful as a “where there’s smoke, read the footnotes” prompt.

(Note: Approach screening tools from the right angle. Use them to identify candidates for deeper reading, not as an overarching skeleton doctrine to make a buy/sell decisions by themselves).

• If a screen flags a company, focus on the specific drivers: receivables vs sales, margin deterioration, rising accruals, or increasing leverage.
• Always cross-check with: cash flow statement, revenue recognition footnotes, non-GAAP reconciliations.

What to Do If a Company You Own Starts Showing These Signals

When the fundamentals and the headline numbers diverge, your edge comes from process, not prediction. You’re trying to avoid being the last person to realize that the “growth story” depends on accounting, incentives, or constant funding.

1. Write down the bull thesis in one paragraph, then list 3 numbers that must be true for the thesis to hold (example: gross margin stabilizes, operating cash flow turns positive, churn improves).
2. Set a review cadence (e.g., each quarter) to check those numbers in the 10-Q, not just in the earnings deck.
3. If management changes KPI definitions or increases “adjustments,” treat that as a request for more skepticism, not less.
4. If the balance sheet keeps absorbing the “growth” (receivables/inventory rising, capitalization increasing), require a clear, consistent explanation over multiple quarters.
5. If you can’t reconcile the story to cash and footnotes, consider reducing position size until clarity improves.

How to Verify Claims (Without Paying for Data Platforms)

If you do only one thing, do this: use original filings. Press releases and social posts are curated. Filings are limited by disclosure rules and usually include the reconciliations and footnotes you need.

• Use SEC EDGAR to find 10-K and 10-Q filings and start with the financial statements + footnotes.
• Use the SEC’s beginner guides to understand how the net income is reconciled to operating cash flow and why the footnotes matter.
• If the company uses non-GAAP measures, read the SEC guidance so you know what “equal or greater prominence” and reconciliation requirements are trying to prevent.
• If the company emphasizes KPIs/metrics, look for a stable definition, clear calculation method, and an explanation of why the metric is useful and how it changed (the SEC has specific guidance on this in MD&A).

FAQ